Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: implications for hyperbilirubinemia - Miners, J O; Chau, N; Rowland, A (Biochem Pharmacol, 2017)